EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Aesthetic doctors’ perception and attitudes toward tolerance in botulinum toxin

Seung Min Oh iD, Hyoung Moon Kim, Tae Hwan Ahn, Min Soo Park, Yoo-Seock Ree, Eun Soo Park

Skin Research and Technology · 2024

DOI: 10.1111/srt.13691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Seung Min Oh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gangnam ON Clinic, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Cosmetic Techniques, Physicians, Neuromuscular Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Botulinum toxin is a crucial therapeutic tool with broad indications in both cosmetic and medical fields. However, the expanding cosmetic use and increased dosages of botulinum toxin have raised concerns about resistance, making it essential to study the awareness and management practices among healthcare professionals.

Methods

A survey was conducted among clinical physicians using botulinum toxin. The study investigated their experiences, awareness, and management practices related to toxin resistance. Real‐time mobile app‐based surveys were administered to clinicians attending the 45th International Academic Conference of the Korean Academy of Laser and Dermatology (KALDAT) on December 3, 2023.

Results

Among 3140 participants, 673 clinical physicians completed the survey. Of these, 363 clinicians (53.9%) reported experiencing botulinum toxin resistance. Regarding the resistance rate, 59.4% indicated less than 1%, 36% reported approximately 1%–25%, and 95.4% reported less than 25%. Efforts to prevent resistance included maintaining intervals of over 3 months (54.8%), using products with lower resistance potential (47.0%), employing minimal effective doses (28.2%), and minimizing re‐administration (14.9%).

Conclusion

In the South Korean aesthetic medicine community, a majority of clinical physician's report encountering botulinum toxin resistance. Given the potential loss of various benefits associated with resistance, there is a need to establish appropriate guidelines based on mechanistic studies and current status assessments. Educating clinicians on applicable guidelines is crucial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ACosmetic TechniquesPhysiciansNeuromuscular AgentsHumansEstheticsPerception

Stichwörter der Autor:innen

aesthetic doctorbotulinum toxinprevention of toxin resistancetolerance

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Gangnam ON Clinic, Seoul, Republic of Korea.
  • Maylin Clinic Ilsan Branch, Goyang-si, Gyeonggi-do, Republic of Korea.
  • Department of Anatomy & Cell Biology, Gachon University College of Medicine, Incheon, Republic of Korea.
  • Fresh Plastic Surgery Clinic, Seoul, Republic of Korea.
  • Gangnam View Best Clinic, Pyeongtaek-si, Gyenggi-do, Republic of Korea.
  • Department of Plastic and Reconstructive Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea.

ORCID-Profile: Seung Min Oh

Zitieren

APA

Oh, S. M., Kim, H. M., Ahn, T. H., Park, M. S., Ree, Y. S., & Park, E. S. (2024). Aesthetic doctors’ perception and attitudes toward tolerance in botulinum toxin. Skin Research and Technology. https://doi.org/10.1111/srt.13691

Vancouver

Oh SM, Kim HM, Ahn TH, Park MS, Ree YS, Park ES. Aesthetic doctors’ perception and attitudes toward tolerance in botulinum toxin. Skin Research and Technology. 2024. doi:10.1111/srt.13691

BibTeX
@article{Oh2024,
  author = {Oh, Seung Min and Kim, Hyoung Moon and Ahn, Tae Hwan and Park, Min Soo and Ree, Yoo-Seock and Park, Eun Soo},
  title = {Aesthetic doctors’ perception and attitudes toward tolerance in botulinum toxin},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.13691}
}
Kostenlos starten →